FOSL1 and neoplasm: CDDP treatment significantly reduced tumor volume; however, the Fra-1 + CDDP group displayed larger tumor volumes, enhanced growth rates, and decreased sensitivity to CDDP compared to the null + CDDP group (P < 0.01) [Figure 7A and B].